| US 7,608,705 B2 | ||
| Oligonucleotides, agents containing these oligonucleotides, and the use thereof | ||
| Ernst Bayer, Tübingen (Germany); Inge Bayer, legal representative; Thomas Ketterer, Tübingen (Germany); Holger Kalthoff, Hamburg (Germany); Hendrik Ungefroren, Hamburg (Germany); Michael Gerster, München (Germany); and Alexander Fiedler, Bonn (Germany) | ||
| Assigned to Universitatsklinikum Schleswig-Holstein, Kiel (Germany) | ||
| Appl. No. 10/381,869 PCT Filed Sep. 28, 2001, PCT No. PCT/EP01/11258 § 371(c)(1), (2), (4) Date Aug. 24, 2004, PCT Pub. No. WO02/26754, PCT Pub. Date Apr. 04, 2002. |
||
| Claims priority of application No. 100 48 091 (DE), filed on Sep. 28, 2000. | ||
| Prior Publication US 2005/0019761 A1, Jan. 27, 2005 | ||
| Int. Cl. C07H 21/04 (2006.01) | ||
| U.S. Cl. 536—24.5 [536/24.31; 435/6; 435/325; 435/375; 514/44] | 2 Claims |
| 1. An oligonucleotide consisting of:
5′-tocopheryl-TGC TCC CCC CTG GCT-3′-PEG1500 (SEQ ID NO:1); or
5′-tocopheryl-TGC TCC CCC CTG GCT-3′-tocopheryl (SEQ ID NO:1).
|